LSG and RYGB-induced upregulation of apoA-IV is beneficial for insulin secretion and energy expenditureChinese and Singaporean researchers have discovered that apolipoprotein A-IV (apoA-IV) was significantly increased in diabetic patients...
Tirzepatide reduced sleep apnoea severity by up to nearly two-thirds in adults living with OSA and obesityEli Lilly and Company has announced positive topline results from the SURMOUNT-OSA phase 3 clinical trials that showed tirzepatide...
Journal Watch 17/04/2024Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
The status of bariatric surgery in EgyptWith approximately 100 million inhabitants, Egypt is the 14th-most populated country in the world, and the third-most populated in...
The evolution of the UK’s National Bariatric Surgery RegistryIn October 2023, Mr Omar Khan was appointed as the Chair of the British Obesity & Metabolic Surgery Society’s (BOMSS) National Bariatric...
Endoscopic sleeve gastroplasty more cost-effective than with semaglutideAn economic evaluation comparing endoscopic sleeve gastroplasty (ESG) with semaglutide for treating class II obesity has suggested ESG is...
LSG and RYGB-induced upregulation of apoA-IV is beneficial for insulin secretion and energy expenditure2 days ago
Tirzepatide reduced sleep apnoea severity by up to nearly two-thirds in adults living with OSA and obesity2 days ago